(Senior) Scientist Assay Development (m/f/d)

Biologist/ Biochemist/ Chemist (m/f/d)






Working within an interdisciplinary team, you will be responsible for Multiplex assay development for our proprietary LUNARIS™ platform, from definition of requirements to writing of validation reports. You will guide a technical team with project management and experimental planning while you will be responsible for the evaluation of experimental data, documentation, and reporting.

You will represent AYOXXA through interactions with internal and external partners and stakeholders.

We offer

  • Modern innovative working environment
  • Open-ended employment contract
  • Work in a highly motivated, international team

You offer

  • PhD in life sciences, or other biomedical science related discipline and at least 2 years of post­doctoral academic or industry experience
  • Profound hands-on experience in (immuno) assay development and validation (experience in the field of protein multiplexing would be advantageous)
  • Experience in the field of immunology, ophthalmology or oncology preferred
  • Experience as project and/or team leader
  • Ability to work in interdisciplinary teams
  • Excellent analytical, technical and problem solving skills
  • Proactive and independent mode of operation
  • Excellent communication skills
  • Good knowledge of data analysis and interpretation tools (e.g. GraphPad Prism), knowledge of statistics and related software is a plus
  • First experience with GLP, GMP or related regulations would be desired

If you are interested please e-mail a cover letter, CV, certificates and recommendation letter in one pdf file to career@ayoxxa.com.

AYOXXA Newsletter

Be the first to know! Get regular news on AYOXXA and our products.

* The following fields are required for signing up our newsletter.


Get in touch with us to ask questions, get help, or discuss a project.


* The following fields are required for sending a request.

Connect with AYOXXA

Follow news and developments on these networks and platforms.